Wockhardt Shares Jump 6% on USFDA NDA Acceptance for Zaynich
Wockhardt's share price surged over 6% after the USFDA accepted its New Drug Application for Zaynich, a novel antibiotic. Discover the details and market impact.
Category : Search result: Wockhardt
Wockhardt's Zaynich NDA Accepted by USFDA, Shares Soar 19%
Mumbai's Wockhardt creates history as USFDA accepts its New Drug Application for antibiotic Zaynich, a first for an Indian firm. Shares surge 19%. Read more.
Wockhardt Stock Jumps on US FDA Nod for Novel Antibiotic
Wockhardt shares surged 19.3% after US FDA accepted its New Drug Application for Zaynich, a first-in-class antibiotic. This marks a historic first for an Indian pharma company's New Chemical Entity.
Pujara's brother-in-law found dead in Rajkot home
Jeet Rasik Pabari, brother-in-law of cricketer Cheteshwar Pujara, was discovered dead at his Rajkot residence. Police investigating the sudden death. Read full details.
Page 1 of 1